Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Aliment Pharmacol Ther. 2020 May 13;51(12):1233–1246. doi: 10.1111/apt.15750

Figure 4.

Figure 4.

Forest Plot for studies reporting on surgical rate of small bowel Crohn’s disease strictures treated with intralesional medications post endoscopic balloon dilation. Random effects model demonstrating a pooled event rate for surgical resection 18.5% (95% CI: 8.3–36.2%, I2: 62%, t2 58.2%) over a median follow up time of 21.8 months (range 5–47). *intralesional infliximab, all other studies utilized intralesional corticosteroids.